Background: In phenylketonuria (PKU), treatment monitoring is based on frequent blood phenylalanine (Phe) measurements, as this is the predictor of neurocognitive and behavioural outcome by reflecting brain Phe con-centrations and brain biochemical changes. Despite clinical studies describing the relevance of blood Phe to out-come in PKU patients, blood Phe does not explain the variance in neurocognitive and behavioural outcome completely. Methods: In a PKU mouse model we investigated 1) the relationship between plasma Phe and brain biochemistry (Brain Phe and monoaminergic neurotransmitter concentrations), and 2) whether blood non-Phe Large Neutral Amino Acids (LNAA) would be of additional value to blood Phe concentrations to explain brain...
To unravel the role of gene mutations in the healthy and the diseased state, countless studies have ...
BACKGROUND: Phenylketonuria treatment consists mainly of a Phe-restricted diet, which leads to subop...
Central nervous system (CNS) deficiencies of the monoamine neurotransmitters dopamine and serotonin ...
BACKGROUND: In phenylketonuria (PKU), treatment monitoring is based on frequent blood phenylalanine ...
Background: In phenylketonuria (PKU), treatment monitoring is based on frequent blood phenylalanine ...
Phenylketonuria (PKU) is an inherited metabolic disease characterized by abnormally high concentrati...
Phenylketonuria (PKU) is an inherited metabolic disease characterized by abnormally high concentrati...
In untreated phenylketonuria (PKU), deficiency of phenylalanine hydroxylase (PAH) results in elevate...
In untreated phenylketonuria (PKU), deficiency of phenylalanine hydroxylase (PAH) results in elevate...
Objectives To compare the neurocognitive outcomes of patients with phenylketonuria (PKU) to determin...
Phenylketonuria (PKU) is one of the most common human inborn errors of metabolism, caused by phenyla...
To unravel the role of gene mutations in the healthy and the diseased state, countless studies have ...
BACKGROUND: Phenylketonuria treatment consists mainly of a Phe-restricted diet, which leads to subop...
Central nervous system (CNS) deficiencies of the monoamine neurotransmitters dopamine and serotonin ...
BACKGROUND: In phenylketonuria (PKU), treatment monitoring is based on frequent blood phenylalanine ...
Background: In phenylketonuria (PKU), treatment monitoring is based on frequent blood phenylalanine ...
Phenylketonuria (PKU) is an inherited metabolic disease characterized by abnormally high concentrati...
Phenylketonuria (PKU) is an inherited metabolic disease characterized by abnormally high concentrati...
In untreated phenylketonuria (PKU), deficiency of phenylalanine hydroxylase (PAH) results in elevate...
In untreated phenylketonuria (PKU), deficiency of phenylalanine hydroxylase (PAH) results in elevate...
Objectives To compare the neurocognitive outcomes of patients with phenylketonuria (PKU) to determin...
Phenylketonuria (PKU) is one of the most common human inborn errors of metabolism, caused by phenyla...
To unravel the role of gene mutations in the healthy and the diseased state, countless studies have ...
BACKGROUND: Phenylketonuria treatment consists mainly of a Phe-restricted diet, which leads to subop...
Central nervous system (CNS) deficiencies of the monoamine neurotransmitters dopamine and serotonin ...